Novel CSF biomarkers for frontotemporal lobar degenerations.

Objective: To identify antemortem CSF diagnostic biomarkers that can potentially distinguish between the 2 main causes of frontotemporal lobar degeneration (FTLD), i.e., FTLD with TDP-43 pathology (FTLD-TDP) and FTLD with tau pathology (FTLD-tau).Methods: CSF samples were collected antemortem from 2...

Descripción completa

Detalles Bibliográficos

Publicado en:	Neurology Vol. 75; no. 23; pp. 2079 - 2087
Autores principales:	Hu WT, Chen-Plotkin A, Grossman M, Arnold SE, Clark CM, Shaw LM, McCluskey L, Elman L, Hurtig HI, Siderowf A, Lee VM, Soares H, Trojanowski JQ, Hu, W T, Chen-Plotkin, A, Grossman, M, Arnold, S E, Clark, C M, Shaw, L M, McCluskey, L
Formato:	research Journal Article
Publicado:	Lippincott Williams & Wilkins 12/7/2010
Acceso en línea:	Ver este registro en EBSCOhost